Qol Holdings Co., Ltd.
Financial Summary [Japanese Standards] for the Fiscal Year Ending March 2026 | Sales of 290.7 billion yen (YoY +8.3%)
For the fiscal year ending March 2026, sales reached 290.7 billion yen (YoY +8.3%), operating income was 14.8 billion yen, and net income was 7.4 billion yen, achieving both revenue growth and profit increase. Future outlook remains robust.
Key Figures
- Sales: 290.7 billion yen (YoY +8.3%)
- Operating Income: 14.8 billion yen (YoY +11.4%)
- Net Income: 7.4 billion yen (YoY +5.3%)
AI要約
Performance Overview
Quol Holdings Co., Ltd. achieved sales of 290.7 billion yen (YoY +8.3%), operating income of 14.8 billion yen (+11.4%), and net income of 7.4 billion yen (+5.3%) for the fiscal year ending March 2026. The expansion of pharmaceuticals sales and dispensing services strengthened the earnings base. Along with sales growth, profit margins also improved, demonstrating stable growth.
Future Outlook
The company will continue expanding its healthcare and dispensing businesses, strengthening existing stores and opening new ones. The medium-term management plan targets sales of 350 billion yen and operating income of 20 billion yen, aiming for sustainable growth and profitability improvement. Additionally, efforts toward environmental sustainability and ESG initiatives will be prioritized to enhance corporate value.
Quol Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
